Spyre Therapeutics, Inc.
8 clinical trials · Sponsor
◉ Watch Spyre Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) (NCT07766005) | Spyre Therapeutics, Inc. | 2026-09-01 |
| Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD (NCT07652294) | Spyre Therapeutics, Inc. | 2026-06-08 |
| A Study of SPY072 in Rheumatic Disease (NCT07148414) | Spyre Therapeutics, Inc. | 2025-08-21 |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis (NCT07012395) | Spyre Therapeutics, Inc. | 2025-05-27 |
| A Study of SPY003-207 in Healthy Volunteers (NCT06873724) | Spyre Therapeutics, Inc. | 2025-03-10 |
| A Study of SPY002-091 in Healthy Volunteers (NCT06672718) | Spyre Therapeutics, Inc. | 2024-11-26 |
| A Study of SPY002-072 in Healthy Volunteers (NCT06622070) | Spyre Therapeutics, Inc. | 2024-11-18 |
| A Study of SPY001-001 in Healthy Volunteers (NCT06448247) | Spyre Therapeutics, Inc. | 2024-06-06 |
Track Spyre Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.